Foresite Capital Management VI as of June 30, 2026
Portfolio Holdings for Foresite Capital Management VI
Foresite Capital Management VI holds 23 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 26.2 | $168M | 2.4M | 71.05 | |
| Alumis (ALMS) | 18.6 | $120M | 4.2M | 28.14 | |
| Seaport Therapeutics | 6.0 | $39M | 1.8M | 21.72 | |
| Denali Therapeutics (DNLI) | 5.6 | $36M | 1.4M | 25.72 | |
| Celldex Therapeutics (CLDX) | 5.1 | $33M | 880k | 37.21 | |
| Agios Pharmaceuticals (AGIO) | 4.5 | $29M | 785k | 37.11 | |
| Corvus Pharmaceuticals (CRVS) | 4.3 | $27M | 1.8M | 14.94 | |
| Parabilis Medicines | 4.3 | $27M | 999k | 27.37 | |
| GH Research Ord (GHRS) | 3.9 | $25M | 941k | 26.88 | |
| Jade Biosciences (JBIO) | 3.1 | $20M | 887k | 22.22 | |
| Hinge Health Cl A (HNGE) | 2.8 | $18M | 220k | 83.00 | |
| Kymera Therapeutics (KYMR) | 2.6 | $17M | 146k | 114.67 | |
| Ataibeckley (ATAI) | 2.3 | $15M | 2.8M | 5.27 | |
| Verastem (VSTM) | 1.9 | $12M | 3.1M | 3.82 | |
| Beam Therapeutics (BEAM) | 1.8 | $11M | 330k | 34.32 | |
| Minerva Neurosciences (NERV) | 1.7 | $11M | 2.0M | 5.55 | |
| Arrivent Biopharma (AVBP) | 1.6 | $11M | 301k | 34.74 | |
| Aura Biosciences (AURA) | 1.5 | $9.5M | 1.3M | 7.10 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $7.9M | 212k | 37.42 | |
| Research Alliance Corp III Cl A | 0.5 | $3.2M | 300k | 10.70 | |
| Zura Bio Cl A (ZURA) | 0.4 | $2.7M | 450k | 5.90 | |
| Kailera Therapeutics | 0.1 | $826k | 38k | 22.03 | |
| Disc Medicine (IRON) | 0.0 | $71k | 970.00 | 73.14 |
